I'm just amazed that there wasn't a greater reaction to the story (Breast cancer tests at overload) - we have additional non invasive capacity in the award winning Fermiscan with a proven and more effective test and ...yawn. The only good thing about today is that I was able to buy more at a price which will be lost in the rounding down when the stock gets back to $2+.